We offer our clients an array of unique services aimed at improving patient outcomes while reducing overall cost of care. These services can benefit all healthcare stakeholders, including insurers, Accountable Care Organizations (ACOs), Pharmacy Benefit Managers (PBMs), physicians, and patients.

We offer our clients an array of unique services aimed at improving patient outcomes while reducing overall cost of care. These services can benefit all healthcare stakeholders, including insurers, Accountable Care Organizations (ACOs), Pharmacy Benefit Managers (PBMs), physicians, and patients.

Urine Drug Testing (UDT)

Quantitative urine drug testing with LC-MS/MS technology is the established gold standard for clinical medication monitoring used by health care providers across many medical specialties, including pain management, primary care, addiction treatment, behavioral health, and OBGYN.

Urine Drug Testing (UDT)

Quantitative urine drug testing with LC-MS/MS technology is the established gold standard for clinical medication monitoring used by health care providers across many medical specialties, including pain management, primary care, addiction treatment, behavioral health, and OBGYN.

pills

Monitor prescribed medications and support clinical decision making

mag-2-70x70

Identify risks for severe and major drug interactions via Precision DDI™

paper

View patient results in various readily-available platforms, including Precision Analytics

Classify test results as consistent or inconsistent with a patient’s treatment plan and/or self-report

newicon1

Detect potential abuse, misuse, and diversion

docs

Choice of cutoff levels- standard or NextGen Precision Testing

NextGen Precision Testing

The platform that raised the drug testing industry standard.

Our retrospective analysis of over 46,000 anonymized patient results concluded that industry standard cutoff levels are not appropriately set to identify a significant number of positive test results that were otherwise being reported as negative. False negatives can ultimately cause prescribers to doubt their patients’ adherence to a prescribed regimen or result in a missed opportunity to intervene in the case of a missed unexpected positive drug test result.

This analysis was the incentive in launching the NextGen Precision Testing solution. This solution was developed to improve clinical data through statistically derived cutoff levels that optimize technological advances in LC-MS/MS, giving healthcare providers the best possible information to improve patient outcomes.

Oral Fluid Testing (OFT)

Providing a urine specimen may be challenging for some patients or in certain clinical settings. OFT can be easily observed, is non-invasive, and provides accurate real-time data.

Oral Fluid Testing (OFT)

Providing a urine specimen may be challenging for some patients or in certain clinical settings. OFT can be easily observed, is non-invasive, and provides accurate real-time data.

chart-70x70

Expanded metabolite test panel includes many common prescription medications and drugs of abuse, misuse, or diversion.

mag-2-70x70

Identify risks for severe and major drug-drug interactions via Precision DDI™

Classify test results as consistent or inconsistent with a patient’s treatment plan and/or self-report

pills

Monitor prescribed
medications and support clinical decision making

newicon1

Detect potential abuse,
misuse, and diversion

paper

View patient results in various readily-available platforms, including Precision Analytics

Precision Drug-Drug Interactions (DDI)™

A dashboard within Precision Analytics displays metrics for patient drug-drug interactions, including DDI level classification, DDI drug contribution metrics, and drugs not ordered resulting in missed DDIs. Precision DDI™ promotes better patient outcomes by providing the option for new dialogue between clinicians and their patients in order to decrease the illicit utilization of life-threatening drug combinations.

Drug interaction descriptions for Precision DDI™ are verified by Elsevier’s Gold Standard Drug Database (GSDD) and are also available to providers as a no-cost report enhancement option on all formats of Precision’s Test Reports.

Precision Drug-Drug Interactions (DDI)™

A dashboard within Precision Analytics displays metrics for patient drug-drug interactions, including DDI level classification, DDI drug contribution metrics, and drugs not ordered resulting in missed DDIs. Precision DDI™ promotes better patient outcomes by providing the option for new dialogue between clinicians and their patients in order to decrease the illicit utilization of life-threatening drug combinations.

Drug interaction descriptions for Precision DDI™ are verified by Elsevier’s Gold Standard Drug Database (GSDD) and are also available to providers as a no-cost report enhancement option on all formats of Precision’s Test Reports.

Precision Analytics

A customizable dashboard to display data in an infinite number of ways to help manage patient drug testing information, including prescription adherence metrics, test utilization history, specific drug information, risk stratification, and tracking patient trends and outcomes.

Precision Analytics

A customizable dashboard to display data in an infinite number of ways to help manage patient drug testing information, including prescription adherence metrics, test utilization history, specific drug information, risk stratification, and tracking patient trends and outcomes.

Precision Integration

Precision can provide the best interoperability (integration) solution that fits seamlessly with our customers’ clinical workflows. We partner with the leading-edge integration vendors that include front end integrations, standard HL7 integrations, and demographic bridges. Additionally, we work with many custom-built EHR systems.

Precision Integration

Precision can provide the best interoperability (integration) solution that fits seamlessly with our customers’ clinical workflows. We partner with the leading-edge integration vendors that include front end integrations, standard HL7 integrations, and demographic bridges. Additionally, we work with many custom-built EHR systems.

Billing

Precision Diagnostics is committed to complete pricing transparency,
demonstrating that integrity makes a difference when choosing a laboratory partner.

We are enrolled in Medicare and in all Medicaid programs. Our fee schedule matches Medicare’s clinical drug testing tiered billing structure for CMS and self-pay patients who do not have medical insurance. For most commercial health plans, Precision bills at approximately 1.5 times the Medicare Fee Schedule, clearly listing our pricing model on every Test Requisition Form.

We are proud to be in-network nationally with most major insurance companies, along with more than 200 state and regional plans throughout the country. At Precision we consider ourselves stewards of healthcare dollars and continuously work to obtain in-network contracts with commercial health plans. We know in-network is preferred, as it is the most patient-friendly option and the option most preferred by providers.

Information for Patients

View our Billing Policy.

To view and pay your bill online visit the Patient Payment Portal.

To speak with someone from our billing
department please call (800) 635-6901 Ext. 1.
Representatives are available 5:00AM – 4:00PM (PST).

Patient Assistance Program

As part of our commitment to patient care, Precision Diagnostics works with providers and their patients to address individual patient financial responsibility in a manner that is fair and sensitive to individual patient and household circumstances.